pharmaceutical market competition

The obesity drug market is seeing intensified competition as pharmaceutical giants battle for dominance. Recently, shares of Novo Nordisk and Eli Lilly, two of the leading companies in the obesity drug sector, experienced a significant drop. This decline was primarily triggered by positive developments in Roche’s obesity drug trial, signaling potential new competition in the…